HomeInsightsEPS

Dr Reddys Laboratories Ltd EPS

Dr Reddys Laboratories Ltd EPS

stocks purchased

₹ 59.8 Cr

Volume Transacted

(Dec 24, 2024)

stocks purchased

442.3 K

Stocks Traded

(Dec 24, 2024)

Last Updated on: Dec 25, 2024

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

EPS

₹ 63.98

Last updated on: Dec 24, 2024

Key Highlights

  • The Earning per Share of Dr Reddys Laboratories Ltd is ₹ 63.98 as of 24 Dec 24 .
  • The earning per share of Dr Reddys Laboratories Ltd changed from ₹ 71.64 to ₹ 75.4 over 10 quarters. This represents a CAGR of 2.07% .

Historical Earning per Share of Dr Reddys Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Dr Reddys Laboratories Ltd

Market Cap

112,749 Cr

EPS

64.0

P/E Ratio (TTM) *

21.1

P/B Ratio (TTM) *

3.7

Day’s High *

1365.0

Day’s Low

1336.7

DTE *

0.2

ROE *

17.4

52 Week High

1420.2

52 Week Low

1104.69

ROCE *

20.7

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Dec 20241351.25
23 Dec 20241340.8
20 Dec 20241342.45
19 Dec 20241326
18 Dec 20241275.05
17 Dec 20241248
16 Dec 20241269.9
13 Dec 20241246.3
12 Dec 20241245.95
11 Dec 20241238.45

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

1,12,750

Asset Value

21,458

4.3 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Dr Reddys Laboratories Ltd631,12,749
Sun Pharmaceuticals Industries Ltd464,36,103
Divis Laboratories Ltd691,53,540
Mankind Pharma Ltd511,20,073
Cipla Ltd571,19,196
Torrent Pharmaceuticals Ltd511,15,107

Historical Market Cap of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories to convene board meeting

Dr Reddys Laboratories will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

24 Dec 2024 10:51

News

DRL arm incorporates new WOS to expand operations in Finland

According to the exchange filing, the subsidiary was officially established on 20 December...

Read more

24 Dec 2024 11:16

News

Dr Reddys Laboratories allots 13,080 equity shares under ESOS

Dr Reddys Laboratories has allotted 13,080 equity shares under ESOS on 19 December 2024. P...

Read more

20 Dec 2024 09:31

News

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting...

Read more

20 Dec 2024 13:05

News

Dr Reddys launches immuno-oncology drug - Toripalimab in India

Dr Reddys Laboratories announced the launch of Toripalimab in India. Toripalimab is a New ...

Read more

28 Nov 2024 09:14

News

Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India

Toripalimab is the only immuno-oncology drug approved by various regulatory authorities ar...

Read more

28 Nov 2024 10:11

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Aug 2024

Transcript

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Nov 2023

Transcript

July 2023

TranscriptPPT

May 2023

Transcript

Jan 2023

Transcript

Nov 2022

Transcript

June 2022

TranscriptPPT

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

May 2020

Transcript

Jan 2020

Transcript

FAQs for EPS of Dr Reddys Laboratories Ltd

What is the EPS of Dr Reddys Laboratories Ltd stock?

The Earnings Per Share (EPS) of Dr Reddys Laboratories Ltd is 63.98. An EPS is the amount of net income attributed to each share of a common stock.

How is Dr Reddys Laboratories Ltd EPS calculated?

The EPS of Dr Reddys Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Dr Reddys Laboratories Ltd report its EPS?

Dr Reddys Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Dr Reddys Laboratories Ltd EPS?

Factors that influence the EPS of Dr Reddys Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Dr Reddys Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Dr Reddys Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions